Apixaban is a safe option for pediatric patients with a variety of congenital or acquired heart diseases who require chronic anticoagulation for thromboprophylaxis, the randomized SAXOPHONE study ...

The National Institutes of Health has awarded the Icahn School of Medicine at Mount Sinai an $8.5 million renewal grant to ...

In the PANORAMA-HF trial, children receiving sacubitril/valsartan for their heart failure experienced clinically meaningful improvements similar to those seen in children receiving enalapril, although ...

When the patient arrived, she was breathing faster than normal and had been progressively tired and sweaty when feeding. Her temperature was 97.7 °F, with pulse of 175, respiration 70, blood pressure ...

Renowned visionary English physician William Harvey wrote in 1651 about how our blood contains all the secrets of life. “And so I conclude that blood lives and is nourished of itself and in no way ...

The US Food and Drug Administration (FDA) has approved sacubitril/valsartan (Entresto, Novartis) for the treatment of symptomatic heart failure (HF) with systemic left ventricular systolic dysfunction ...

Ochsner Children's Hospital, ranked among the top hospitals in the nation for pediatric cardiology and congenital heart surgery, is raising awareness of the need for more pediatric-specific heart ...

Children and adolescents diagnosed with high blood pressure have double the risk of major cardiovascular problems as adults, a new study that followed them into their 20s and 30s reports. It’s another ...

An 11-year-old girl in Colorado is now able to live a healthier life after the Children’s Hospital Colorado in Aurora was ...

When Kelsey Brown met Mohammed, the 15-year-old Ugandan boy looked terribly worried. He was in the late stages of rheumatic heart disease, which kills about 400,000 people a year worldwide. His ...